
Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphoma
Author(s) -
Héloïse Delagrèverie,
Laurence Gérard,
Antoine Chaillon,
Marie Roelens,
Lounes Djerroudi,
Maud Salmona,
Jérôme Larghero,
Lionel Galicier,
François Simon,
Éric Oksenhendler,
Hélène MoinsTeisserenc,
Constance Delaugerre
Publication year - 2019
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002051
Subject(s) - lymphoma , hematopoietic stem cell transplantation , viral load , immunology , autologous stem cell transplantation , chemotherapy , transplantation , peripheral blood mononuclear cell , biology , oncology , medicine , human immunodeficiency virus (hiv) , biochemistry , in vitro
Autologous stem cell transplantation following high-dose chemotherapy (HDC/ASCT) is the prime model to study the impact of HDC in HIV-1-infected participants. We analyzed the impact of HDC/ASCT on the resurgent reservoir composition and origin.